[video] Is Kenya on track to end TB by 2030?

[podcast] Is Kenya on track to end TB in next 88 months?


This podcast features Evaline Kibuchi, noted #endTB activist and leader, and Chief National Coordinator of Stop TB Partnership Kenya. She is a global health advocate with a key focus on TB with over ten years in advocacy.

Listen to this podcast on Apple Podcasts, Amazon Music, Google Podcasts, Spotify, TuneIn, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, Player FM, and other podcast streaming platforms.

[video] Taiwan's laws for same sex marriage and co-adoption rights give hope

[podcast] Laws for same sex marriage and adoption rights give hope in Taiwan


This podcast features Jennifer Lu, Director for Asia Programmes, Outright International. She is a dedicated activist for LGBTQIAP+ rights and political reform movements for over 20 years nationally and internationally. She is a social worker, lesbian feminist, author, and Taiwanese. Before joining Outright, Jennifer was Executive Director of Taiwan Equality Campaign, known as Marriage Equality Coalition Taiwan - a leading organization that pushed marriage equality in Taiwan.

She was speaking as part of the #GenderEquality Talks #GETalksLive (season-2) #90for90 #GlobalVoices series.

Listen to this podcast on Apple Podcasts, Amazon Music, Google Podcasts, Spotify, Stitcher, TuneIn, aCast, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, Player FM, and other podcast streaming platforms.

[video] Getting on track to #endTB & #endMalaria is a human rights imperative

[podcast] Ending TB and malaria are human rights imperative, says Aloyce Urassa

This podcast features Aloyce P Urassa from Tanzania, who is a public health scientist specialising in implementation and health systems research with a background in health laboratory sciences. He is currently the chairperson of the African Leaders Malaria Alliance (ALMA) Youth Advisory Council, a Board member of Rotarians Against Malaria - Global, and a Global Fund Advocates Network (GFAN) speaker.

He was speaking as part of the #EndTB Dialogues (season-2) #90for90 #GlobalVoices series.

Listen to this podcast on Apple Podcasts, Amazon Music, Google Podcasts, Spotify, Stitcher, TuneIn, aCast, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, Player FM, and other podcast streaming platforms.

Early and accurate TB diagnosis is the gateway to #endTB pathway



[हिन्दी] If we are to end TB, then we have to find every person with TB and offer accurate and timely diagnosis, treatment, care and support. In other words, we have to eliminate ‘delayed or missed diagnosis’ by making “early and accurate TB diagnosis” a norm, before we can further embark on the #endTB pathway with full force. By doing so, not only people with TB will get treated early on, but we might also have a better shot at breaking the chain of infection transmission.

Long walk to transgender rights and gender equality

Although governments have committed to achieve gender equality by 2030, yet the progress is way off the mark. United Nations Secretary General Antonio Guterres had recently said that it will take another 300 years to achieve full gender equality. More worrying is the fact that transgender and other gender diverse people, often slip on the blind spot when many governments refer to gender equality and see it with sex and gender binary lens (man and woman, or male and female).

[podcast] TB drug and other stock-outs are not acceptable if we are to #endTB in Kenya

This Podcast features Peter Ngo’la Owiti, who is on the Executive Committee Board of Stop TB Partnership, and also represents communities on Medicines Patent Pool. He is also the Executive Director of the Wote Youth Development Projects, Kenya.

Listen to his insights on why stock-outs of medicines for drug-sensitive TB, essential needs which are required to refer patients, or of cartridges to run nucleic acid amplification tests (NAAT) molecular diagnostics such as Gene Xpert are not acceptable.